Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT03523156
Eligibility Criteria:
Cluster (kebele) Inclusion Criteria:
* The kebele must be located in Amhara and eligible for annual MDA with azithromycin under WHO treatment guidelines.
* Located within targeted districts where the prevalence of TF is high (at least 30%) and the prevalence of CT infection is suspected to be high (10% if possible) measured from the most recent trachoma impact assessment.
* The kebele representatives consent to participation in the trial.
Gott (village) Inclusion Criteria:
* At least 50 children residing in the gott.
Child Inclusion Criteria:
* Must reside in a cluster selected for this study.
* Must have a head of household or designated "adult-in-charge" who can provide consent for that child to be included in the study sample and to consent to allowing study staff to collect an ocular swab from the conjunctival epithelium.
* Child must assent to having a swab taken.
* Child must not have an ocular condition which would preclude grading trachoma or taking an ocular specimen.
Exclusion Criteria:
* none
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
9 Years
Study:
NCT03523156
Study Brief:
Protocol Section:
NCT03523156